Floatz logo

Tapentadol

Osteoarthitis

Janssen Pharmaceutical K.K.Small moleculePhase 2Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

31 Active assets in the Osteoarthitis cohort.

Asset / SponsorPhaseRating
Duloxetine
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Phase 4BBB
Naproxen
Pfizer
Phase 3BB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BB
TRIAMCINOLONE HEXACETONIDE
Kastamonu University
Phase 4BB
DEXTROSE SOLUTION
Kastamonu University
Phase 4BB

View all 50 →

Same molecule, other indications

Tapentadol is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →